<?xml version="1.0" encoding="UTF-8"?>
<ref id="B68">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Guirakhoo</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Kitchener</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Morrison</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Forrat</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>McCarthy</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Nichols</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2006</year>). 
  <article-title>Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.</article-title>
  <source>
   <italic>Hum. Vaccin</italic>
  </source>
  <volume>2</volume>
  <fpage>60</fpage>â€“
  <lpage>67</lpage>. 
  <pub-id pub-id-type="doi">10.4161/hv.2.2.2555</pub-id>
  <?supplied-pmid 17012873?>
  <pub-id pub-id-type="pmid">17012873</pub-id>
 </mixed-citation>
</ref>
